Abpro (ABP) Competitors $0.27 +0.01 (+5.72%) As of 08/15/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ABP vs. DRRX, CUE, LTRN, ICCC, HOWL, ANL, TELO, ABVC, PYRGF, and DTILShould you be buying Abpro stock or one of its competitors? The main competitors of Abpro include DURECT (DRRX), Cue Biopharma (CUE), Lantern Pharma (LTRN), ImmuCell (ICCC), Werewolf Therapeutics (HOWL), Adlai Nortye (ANL), Telomir Pharmaceuticals (TELO), ABVC BioPharma (ABVC), PyroGenesis Canada (PYRGF), and Precision BioSciences (DTIL). These companies are all part of the "pharmaceutical products" industry. Abpro vs. Its Competitors DURECT Cue Biopharma Lantern Pharma ImmuCell Werewolf Therapeutics Adlai Nortye Telomir Pharmaceuticals ABVC BioPharma PyroGenesis Canada Precision BioSciences Abpro (NASDAQ:ABP) and DURECT (NASDAQ:DRRX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership. Is ABP or DRRX more profitable? Abpro has a net margin of 0.00% compared to DURECT's net margin of -96.19%. Abpro's return on equity of 0.00% beat DURECT's return on equity.Company Net Margins Return on Equity Return on Assets AbproN/A N/A -241.16% DURECT -96.19%-259.16%-71.78% Do analysts recommend ABP or DRRX? Abpro currently has a consensus price target of $4.00, indicating a potential upside of 1,403.76%. Given Abpro's stronger consensus rating and higher possible upside, equities analysts plainly believe Abpro is more favorable than DURECT.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abpro 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00DURECT 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders have more ownership in ABP or DRRX? 23.3% of Abpro shares are held by institutional investors. Comparatively, 28.0% of DURECT shares are held by institutional investors. 20.8% of Abpro shares are held by company insiders. Comparatively, 3.2% of DURECT shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has better earnings & valuation, ABP or DRRX? Abpro has higher earnings, but lower revenue than DURECT. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbpro$180K89.83-$7.23MN/AN/ADURECT$2.03M29.21-$8.32M-$0.10-19.10 Does the media refer more to ABP or DRRX? In the previous week, DURECT had 8 more articles in the media than Abpro. MarketBeat recorded 10 mentions for DURECT and 2 mentions for Abpro. Abpro's average media sentiment score of 1.63 beat DURECT's score of 0.53 indicating that Abpro is being referred to more favorably in the media. Company Overall Sentiment Abpro Very Positive DURECT Positive Which has more volatility and risk, ABP or DRRX? Abpro has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Comparatively, DURECT has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. SummaryAbpro beats DURECT on 9 of the 14 factors compared between the two stocks. Get Abpro News Delivered to You Automatically Sign up to receive the latest news and ratings for ABP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABP vs. The Competition Export to ExcelMetricAbproMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.29M$3.10B$5.68B$9.81BDividend YieldN/A2.23%3.79%4.11%P/E RatioN/A20.8931.0825.11Price / Sales89.83364.47466.21115.16Price / CashN/A42.3037.4059.05Price / Book-0.958.659.096.18Net Income-$7.23M-$54.65M$3.26B$265.11M7 Day Performance8.13%6.56%7.36%4.21%1 Month Performance21.91%7.53%5.47%2.01%1 Year PerformanceN/A13.69%30.61%23.74% Abpro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABPAbproN/A$0.27+5.7%$4.00+1,403.8%N/A$15.29M$180K0.0015Positive NewsEarnings ReportDRRXDURECT1.8474 of 5 stars$1.85-0.5%N/A+66.1%$57.74M$2.03M-12.3380Earnings ReportShort Interest ↓CUECue Biopharma4.5083 of 5 stars$0.84+10.0%$4.00+377.3%+39.1%$57.42M$9.29M-1.2560Earnings ReportGap UpLTRNLantern Pharma2.9376 of 5 stars$5.20-2.3%$25.00+380.8%+6.5%$57.38MN/A-2.8320Earnings ReportGap UpICCCImmuCell0.5395 of 5 stars$6.17-1.1%N/A+65.3%$56.44M$26.49M-88.1370News CoverageEarnings ReportShort Interest ↓HOWLWerewolf Therapeutics3.7249 of 5 stars$1.21-2.4%$8.33+588.7%-34.2%$55.64M$1.88M-0.7240News CoverageEarnings ReportAnalyst RevisionANLAdlai Nortye1.3663 of 5 stars$1.50flat$9.00+500.0%-44.9%$55.35M$5M0.00127Short Interest ↑Gap UpTELOTelomir Pharmaceuticals2.6173 of 5 stars$1.83flat$15.00+719.7%-63.2%$54.47MN/A-4.361Earnings ReportGap DownABVCABVC BioPharma0.4019 of 5 stars$3.00-6.3%N/A+364.1%$54.34M$510K-23.0830News CoverageEarnings ReportPYRGFPyroGenesis CanadaN/A$0.29-1.5%N/A-58.3%$53.72M$9.14M-4.7890Gap UpDTILPrecision BioSciences4.1248 of 5 stars$4.86+0.4%$47.00+867.1%-45.3%$53.67M$68.70M-2.42200News CoveragePositive NewsAnalyst Revision Related Companies and Tools Related Companies DRRX Alternatives CUE Alternatives LTRN Alternatives ICCC Alternatives HOWL Alternatives ANL Alternatives TELO Alternatives ABVC Alternatives PYRGF Alternatives DTIL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABP) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abpro Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abpro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.